Evidence in humans suggests that SIRT1-mediated pathways aided in resolving NAFLD by increasing NAD + in the liver, but knockdown of SIRT3 does not change liver status38. This evidence concerns the gene SIRT3 and metabolic dysfunction-associated steatotic liver disease.